Short Interest in Trinity Biotech plc (NASDAQ:TRIB) Grows By 58.3%

Trinity Biotech plc (NASDAQ:TRIB) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 1,900 shares, a growth of 58.3% from the March 31st total of 1,200 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 94,300 shares, the short-interest ratio is currently 0.0 days.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on shares of Trinity Biotech in a report on Wednesday, April 24th. They issued a “buy” rating on the stock.

Trinity Biotech Stock Performance

Shares of Trinity Biotech stock opened at $1.83 on Monday. The company’s 50 day moving average price is $2.01 and its 200-day moving average price is $2.23. Trinity Biotech has a 52-week low of $1.79 and a 52-week high of $5.50.

Trinity Biotech (NASDAQ:TRIB) last released its quarterly earnings results on Thursday, April 4th. The company reported ($0.68) earnings per share for the quarter. The company had revenue of $13.43 million for the quarter. Sell-side analysts anticipate that Trinity Biotech will post -1.5 earnings per share for the current fiscal year.

Trinity Biotech Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.